High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma
- PMID: 18056184
- DOI: 10.1158/1078-0432.CCR-07-1222
High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma
Abstract
Purpose: Persistent infections by high-risk human papillomavirus (HPV) types are the main etiologic factor for cervical cancer. The objective of this study was to evaluate whether high-risk E7 oncoprotein is adequate as a marker for the detection of cervical cancer.
Experimental design: HPV typing was done in biopsies from 58 cervical carcinoma and 22 normal cervical squamous epithelia. The HPV-16 E7, HPV-18 E7, and HPV-45 E7 oncoprotein levels were monitored by immunohistochemistry and compared with those of p16(INK4a) and Ki67.
Results: Fifty-five (94.8%) tumors were high-risk HPV-DNA-positive (46 HPV-16, 2 HPV-16 and HPV-18, 4 HPV-18, 1 HPV-33, and 2 HPV-45). HPV-DNA could not be detected in three tumors (5.2%). High HPV E7 oncoprotein levels were shown in 57 cervical cancers (98.3%), without correlation between expression levels and tumor stages.
Conclusion: This is the first study which systematically analyzes the levels of the major HPV oncoproteins in cervical carcinomas demonstrating that the high-risk HPV E7 proteins are regularly expressed in these cancers. This suggests that high-risk E7 oncoproteins are necessary for cervical cancers and apparently essential as tumor marker.
Similar articles
-
Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.Mod Pathol. 2003 Jul;16(7):692-9. doi: 10.1097/01.MP.0000077417.08371.CE. Mod Pathol. 2003. PMID: 12861066
-
Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.Cancer Lett. 2004 Sep 15;213(1):31-7. doi: 10.1016/j.canlet.2004.03.030. Cancer Lett. 2004. PMID: 15312681
-
Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.Cancer. 2002 Apr 15;94(8):2199-210. doi: 10.1002/cncr.10439. Cancer. 2002. PMID: 12001118
-
[Human papilloma virus and cervical cancer].Gan To Kagaku Ryoho. 1995 May;22(6):711-7. Gan To Kagaku Ryoho. 1995. PMID: 7755378 Review. Japanese.
-
Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma.Cancer. 2007 Feb 25;111(1):1-14. doi: 10.1002/cncr.22425. Cancer. 2007. PMID: 17219448 Review.
Cited by
-
Human papillomavirus oncoproteins induce a reorganization of epithelial-associated γδ T cells promoting tumor formation.Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E9056-E9065. doi: 10.1073/pnas.1712883114. Epub 2017 Oct 10. Proc Natl Acad Sci U S A. 2017. PMID: 29073102 Free PMC article.
-
Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes.Virology. 2008 Oct 10;380(1):21-5. doi: 10.1016/j.virol.2008.07.017. Epub 2008 Aug 21. Virology. 2008. PMID: 18718623 Free PMC article.
-
Detection of human papillomavirus type 18 E7 oncoprotein in cervical smears: a feasibility study.J Clin Microbiol. 2012 Feb;50(2):246-57. doi: 10.1128/JCM.01108-11. Epub 2011 Nov 30. J Clin Microbiol. 2012. PMID: 22135254 Free PMC article.
-
Generation and characterization of neutralizing monoclonal antibodies against baculo-expressed HPV 16 VLPs.Eur J Microbiol Immunol (Bp). 2014 Mar;4(1):56-64. doi: 10.1556/EuJMI.4.2014.1.5. Epub 2014 Mar 14. Eur J Microbiol Immunol (Bp). 2014. PMID: 24678406 Free PMC article.
-
A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2).Vaccines (Basel). 2021 Apr 1;9(4):329. doi: 10.3390/vaccines9040329. Vaccines (Basel). 2021. PMID: 33915901 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical